AJU IB Investment Co., Ltd. - Q3 2021 holdings

$155 Million is the total value of AJU IB Investment Co., Ltd.'s 11 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 0.0% .

 Value Shares↓ Weighting
AVIR SellATEA PHARMACEUTICALS INC$57,405,000
+53.1%
1,637,331
-6.2%
37.04%
+71.4%
KYMR  KYMERA THERAPEUTICS INC$37,538,000
+21.1%
639,0590.0%24.22%
+35.5%
SEER  SEER INC$28,189,000
+5.3%
816,3750.0%18.19%
+17.9%
APLS SellAPELLIS PHARMACEUTICALS INC$20,599,000
-69.4%
624,962
-41.3%
13.29%
-65.8%
STRO  SUTRO BIOPHARMA INC$3,306,000
+1.6%
175,0000.0%2.13%
+13.7%
RAPT  RAPT THERAPEUTICS INC$3,090,000
-2.3%
99,5030.0%1.99%
+9.3%
CLSD  CLEARSIDE BIOMEDICAL INC$1,761,000
+23.1%
293,5550.0%1.14%
+37.7%
MTEM  MOLECULAR TEMPLATES INC$1,374,000
-14.2%
204,8090.0%0.89%
-4.0%
KZR  KEZAR LIFE SCIENCES INC$1,114,000
+59.1%
128,9160.0%0.72%
+78.0%
ALRN  AILERON THERAPEUTICS INC$528,000
-18.4%
517,5580.0%0.34%
-8.6%
 BELLICUM PHARMACEUTICALS INC$75,000
-11.8%
25,6510.0%0.05%
-2.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
KYMERA THERAPEUTICS INC8Q3 202240.4%
SEER INC8Q3 202225.9%
RAPT THERAPEUTICS INC8Q3 20225.1%
SUTRO BIOPHARMA INC8Q3 20223.6%
ATEA PHARMACEUTICALS INC4Q3 202147.7%
APELLIS PHARMACEUTICALS INC4Q3 202138.8%
RALLYBIO CORP4Q3 202218.7%
XILIO THERAPEUTICS INC4Q3 202214.9%
CLEARSIDE BIOMEDICAL INC4Q3 20211.1%
MOLECULAR TEMPLATES INC4Q3 20211.0%

View AJU IB Investment Co., Ltd.'s complete holdings history.

Latest filings
TypeFiled
13F-HR/A2022-11-14
13F-HR2022-11-07
13F-HR2022-08-09
13F-HR2022-05-12
13F-HR2022-02-09
13F-HR2021-11-10
13F-HR2021-08-10
13F-HR2021-05-12
13F-HR2021-05-12
42017-11-13

View AJU IB Investment Co., Ltd.'s complete filings history.

Compare quarters

Export AJU IB Investment Co., Ltd.'s holdings